Canonical page: https://sequoia-research.com/writing/best-dst-brokers-2026-what-to-look-for-in-a-broker-s-due-diligence-process
Author: Sequoia Research
Published: 2026-10-18T06:33:39.418Z
Updated: 2026-10-18T06:33:39.418Z

# Best DST Brokers (2026): What to Look for in a Broker’s Due-Diligence Process

## What Is This Article About?

This article explains how to examine the research process behind a Delaware statutory trust (DST) broker's recommendation. It compares selected public descriptions from Realized, 1031 Crowdfunding, and Concorde as accessed in October 2026, while keeping those descriptions separate from completed work on an offering. Original examples show how to test dates, sources, assumptions, and unresolved questions in a research packet. The goal is to help you judge the evidence available for a decision without treating a polished process description as proof of investment quality.

## Table of Contents

- [Start With Evidence of Work on the Exact Offering](#start-with-evidence-of-work-on-the-exact-offering)
- [What Current FINRA Guidance Adds to the Review](#what-current-finra-guidance-adds-to-the-review)
- [Compare the Selected Public Process Descriptions](#compare-the-selected-public-process-descriptions)
- [Map the People Responsible for the Research](#map-the-people-responsible-for-the-research)
- [Build a Source List That Shows What Was Actually Read](#build-a-source-list-that-shows-what-was-actually-read)
- [Trace One Property Claim Through the Research Packet](#trace-one-property-claim-through-the-research-packet)
- [Test the Financial Assumptions Behind the Recommendation](#test-the-financial-assumptions-behind-the-recommendation)
- [Read Third-Party Research With Its Scope and Limits](#read-third-party-research-with-its-scope-and-limits)
- [Look for a Record of Unresolved Questions](#look-for-a-record-of-unresolved-questions)
- [Review Changes Between Approval and Subscription](#review-changes-between-approval-and-subscription)
- [Separate Offering Approval From the Investor Decision](#separate-offering-approval-from-the-investor-decision)
- [Compare Research Access Without Rewarding Page Counts](#compare-research-access-without-rewarding-page-counts)
- [Use a Practical Broker Due-Diligence Interview](#use-a-practical-broker-due-diligence-interview)
- [Frequently Asked Questions](#frequently-asked-questions)
- [About Sequoia Research](#about-sequoia-research)
- [Sources](#sources)

## Start With Evidence of Work on the Exact Offering

A broker may say every investment passes a careful screen. That is a useful starting statement, but it leaves several questions open. What was screened? Which documents were used? Who checked the major assumptions? What changed after the review? And which concerns remained when the broker discussed the investment with you?

The best DST brokers search often produces broad claims about experience, selection, and research. To make those claims useful, move from the firm's general method to one offering you might buy. Ask for the exact legal issuer name, the version of the offering packet, and the date of the research you may inspect.

Keep three kinds of evidence apart. A process description explains how work is supposed to happen. A completed research record shows what happened in a defined review. An outcome record shows what later happened to an investment. Each can matter, but none by itself proves the other two.

For an original example, imagine a firm has a ten-step policy. Its report for a specific DST addresses eight steps and leaves two pending. A later sale produces a gain. The gain does not show that the two pending steps were completed before the recommendation. In the same way, a later loss does not by itself show that every earlier research step was careless.

This article uses a small public sample, not a market-wide ranking. We reviewed the cited pages without opening investor accounts, entering private portals, or requesting confidential firm files. No named broker's full internal research, committee minutes, or completed review of a current offering was audited. When a public page leaves a question unanswered, the correct finding is that the inspected page did not answer it.

That limit is useful. It tells you where your own conversation should begin. It does not justify a claim that a firm failed to perform work merely because the work is not displayed on a public website.

## What Current FINRA Guidance Adds to the Review

The Financial Industry Regulatory Authority (FINRA) addresses reasonable investigations of private placements in Regulatory Notice 23-08. Its discussion covers the issuer, management, business, assets, claims, and use of offering proceeds. It also explains the need to assess third-party material with care, consider the outside source's incentives and qualifications, and resolve warning signs before recommending an offering. The required investigation depends on the facts. A standard checklist alone does not show compliance. [FINRA Regulatory Notice 23-08](https://www.finra.org/rules-guidance/notices/23-08).

FINRA's 2026 oversight report was published in December 2025. Its private-placement section lists concerns such as relying only on past experience with an issuer, failing to resolve warning signs, and lacking records that explain research efforts. It also describes practices aimed at examining material offering claims and changes during an offering. These are industry observations and guidance; they are not findings about the three firms discussed here. [FINRA 2026 oversight report, private placements](https://www.finra.org/rules-guidance/guidance/reports/2026-finra-annual-regulatory-oversight-report/private-placements).

For your review, turn the general issue into a specific request. Instead of asking whether a firm “does due diligence,” ask how it addressed a material assumption in the offering now under discussion. A useful answer should connect the question, source, analysis, and remaining uncertainty.

For example, a business plan may assume a large increase in rents. Ask which records support that increase and whether the broker reviewed the cost of achieving it. A brochure that repeats the sponsor's target does not, by itself, answer those questions.

The examples below are original ways to organize that conversation. They are not a legal compliance checklist or a promise that every investor can obtain every internal document. A firm may have sound reasons to limit access to private material. You can still ask for a clear explanation of the work, its scope, and its limits.

## Compare the Selected Public Process Descriptions

### Realized: Described Review Roles and Research Reports

Realized's broker-dealer partner page says Realized Financial reviews potential investments, including the sponsor, property, and structure. It describes a later review by a due-diligence committee and says only offerings that pass both reviews enter its custom portfolios. The site's disclosure distinguishes the website operator, Realized Technologies, from Realized Financial, through which securities or advisory services may be offered. These are the firm's public statements, not our verification of a completed review. [Realized broker-dealer partner page](https://www.realized1031.com/partners/broker-dealers).

A separate Realized advisor page describes upfront and ongoing reviews and the availability of detailed reports. It also promotes proprietary risk tools. We did not inspect the model itself, inputs, validation record, or a private report for this article. The public description therefore supports asking for the report and method; it does not show predictive accuracy or an independent investment rating. [Realized advisor platform](https://www.realized1031.com/advisor).

The practical follow-up is to ask what you may read for the exact offering. Name the report date, whether the recommendation used that version, and what later events triggered another look. If a risk label appears, ask what it measures before comparing it with another firm's label.

### 1031 Crowdfunding: Document Access and an Evaluation Model

1031 Crowdfunding's platform page advertises document downloads and lists examples such as offering memoranda, forecasts, property reports, appraisals, mortgage records, and leases. It also describes a proprietary evaluation model and indicators shown in its portal. We did not register or inspect a live private packet or model output. The available public page describes access and evaluation features, but it does not let us test their completeness for a named current offering. [1031 Crowdfunding platform page](https://www.1031crowdfunding.com/investment-platform/).

The home page's disclosure says 1031 Crowdfunding is not a registered broker-dealer and that broker-dealer services on the platform are offered through Capulent. Certain principals act as Capulent representatives when offering investment services. Keep that role distinction when asking who performed, approved, or explained an offering review. [1031 Crowdfunding home page and disclosure](https://www.1031crowdfunding.com/).

A useful next request is a document index for the actual packet you can access. Ask whether a displayed metric came from a sponsor forecast, an outside report, or a separate calculation. The fact that a portal holds many files does not tell you whether anyone reconciled conflicting figures across them.

### Concorde: Oversight and the Individual Financial Professional

Concorde's investor page describes support and oversight for independent financial professionals. It presents a model in which those professionals work with investors using the firm's resources. The disclosure separates securities services through Concorde Investment Services from advisory services through Concorde Asset Management. The inspected page does not provide an offering-specific research file or a detailed completed review that we could test. That is a limit of this public source, not evidence that such work does not exist. [How Concorde works](https://www.concordeis.com/how-concorde-works/).

For an investor, the next question concerns the connection between central firm work and the named professional's explanation. Ask which analysis the firm supplies, what the professional adds for your situation, and how unresolved questions move back to the research team. Do not assume that a corporate oversight statement explains every part of that chain.

### What This Comparison Can Establish

These pages describe different pieces of a process: firm review, committee review, research access, a portal, or oversight of professionals. They do not form a matched sample of completed work on the same offering. It would be unsound to award a winner from the amount of detail on these pages alone.

Use the sample to prepare better requests. A firm that describes a committee can be asked about the scope and date of its review. A firm that describes a document portal can be asked for the packet index. A firm that describes oversight can be asked how the firm and representative divide the work. The request follows the claim.

## Map the People Responsible for the Research

Before reading a long report, make a simple role map. Name the sponsor, legal issuer, selling broker-dealer, named representative, outside research provider, and any separate adviser. Include only roles you can support from the records for that offering.

A single person or related group may fill more than one role. That does not by itself settle whether the work is good or bad. It changes the questions you should ask. If the sponsor supplies a forecast and pays for an outside report, ask which parts of the report test the forecast and which parts simply repeat it.

Use verbs in the role map. “Prepared the forecast,” “reviewed the lease,” “approved the offering for the firm's platform,” and “discussed the investment with the client” describe different acts. A list of company names alone can hide those differences.

In an original example, four teams appear on a packet. The sponsor prepared it, a property consultant assessed the buildings, an outside analyst summarized the terms, and the broker's research team made follow-up requests. That is four roles. It does not mean four independent parties verified every figure.

Ask who can answer a question after the sales meeting. A representative may need to route a technical issue to another person. That can be reasonable. What matters is whether the question reaches someone with the needed records and whether the answer returns with enough context to use.

Record the answerer's role along with the response date. If the response is a sponsor statement forwarded by the broker, label it that way. Do not rewrite it as the broker's independent conclusion unless that is what the broker actually says and supports.

## Build a Source List That Shows What Was Actually Read

A source list should explain more than how many files were received. Give each document a title, issuer or subject, date, version, and location. Then record whether the reviewer read the whole document, a selected section, a summary, or a reference to it in another document.

For an original example, a research folder contains twelve files. Three are duplicate copies, two are cover letters, and seven contain distinct source material. Calling this “twelve research reports” would overstate the evidence. Seven distinct documents may still be more than enough for some questions and too little for others.

Keep a separate column for access. A document can be held by the broker but unopen to you. It can be promised but not yet received. It can be listed in a report without being attached. Those states should not collapse into a single checkmark.

Dates need similar care. A report written in October may rely on operations through June. The report's cover date does not refresh the operating data. If the review cutoff is October 17 and the data ends June 30, the data period ends 109 calendar days before the cutoff.

That age does not by itself make the data useless. It tells you to ask what changed during the gap. Perhaps later monthly records exist. Perhaps the property has not issued them. Either answer belongs in the file, along with its effect on the decision.

A useful source list also notes conflicting versions. If the same loan is described in two documents with different maturity dates, do not quietly choose one. Record both references and the question that must be resolved. The list becomes a working map of evidence, rather than a count of attachments.

## Trace One Property Claim Through the Research Packet

Choose a claim that could change the investment decision. Occupancy is a good example because similar words can describe different facts. A packet might discuss units occupied, units leased, rent collected, or revenue compared with a fully leased building. Those measures should not be swapped without explanation.

Consider an original fictional 220-unit property. The rent roll shows 198 units occupied and 209 units covered by signed leases. Occupied units are 90% of the total; leased units are 95%. Eleven signed leases do not yet represent occupied units. Both figures can be correct at the same time.

Suppose a presentation says “95% occupancy.” A careful review asks which definition it used and which date it covers. It does not assume fraud, but it also does not carry the presentation's label into a cash-flow model without checking it.

Next, trace collections. In this example, a month shows $300,000 of billed rent and $285,000 received for those charges. That is a 95% collection ratio for the stated month and billing base. It is not the same 95% as leased units. The same percentage hides a different denominator.

Ask how the research handled concessions, overdue balances, vacant units, and units unavailable for rent. A useful answer names the source fields and explains the treatment. A phrase such as “reviewed occupancy” gives too little detail to reproduce the result.

Then ask what changed after the source date. New move-ins, departures, or payment patterns may affect the current picture. A dated bridge from old data to new data is more useful than a fresh cover page placed on the same old figures.

This small exercise tests the research process without requiring you to rebuild the entire underwriting model. You are looking for a traceable path from a material statement to the record that supports it, with any limits stated clearly.

## Test the Financial Assumptions Behind the Recommendation

A useful research process shows how the numbers connect. Start with a few figures that drive the investment's income and risk. Ask the broker to explain the base case and at least one change that could weaken it. The point is to understand the inputs, not to demand a prediction of the future.

In an original fictional model, annual revenue is $5 million and operating expenses are $2 million. Net operating income is therefore $3 million. If revenue rises 3% while expenses rise 5%, the next year's figures become $5.15 million and $2.10 million. Net operating income becomes $3.05 million, an increase of about 1.67%, not 3%.

That difference is small enough to be missed in a sales discussion and large enough to matter in a model. Ask whether the review applied one growth rate to the whole property or separate rates to revenue and expense lines. Then ask what the assumptions mean for the cash available to investors.

A separate original example starts with $2.8 million of annual net operating income and $2 million of annual debt service. The debt-service coverage ratio is 1.40 times. If income falls 15% to $2.38 million while debt service stays fixed, coverage falls to 1.19 times. This simplified test excludes the exact terms of any real loan covenant; it is an operating stress example.

Do not stop with that ratio. If the base case also needs $300,000 for reserves and other modeled cash uses after debt service, only $500,000 remains in that simplified cash bridge. A proposed $600,000 distribution would exceed that amount by $100,000. The calculation raises a funding question, not proof that a distribution is improper.

The broker should be able to explain which source would fund the gap and where that source appears in the documents. If a reserve draw supplies it, the model should show the reserve balance falling. If an assumption is missing, leave the result unresolved rather than creating a plug that makes the distribution work.

Debt percentages also need named denominators. In another original example, investor-allocated debt is $20 million and total investor offering value is $42 million, made up of $22 million equity plus that debt. Investor leverage is about 47.62%. If property acquisition value is $38 million, the same debt divided by that separate value is about 52.63%. The second ratio is acquisition leverage, not a substitute for the first.

None of these examples describes an inspected offering from the named firms. They show the kind of explanation that lets an investor follow the research instead of merely trusting the final label.

## Read Third-Party Research With Its Scope and Limits

When a packet includes outside research, read the cover and scope before the conclusion. Name the exact offering, the report's date, who commissioned it, and which material the author had. A report about a sponsor's general history may be useful without answering the loan question in today's offering.

Use a simple distinction in your notes: source fact, source author's analysis, broker's analysis, and your unanswered question. This prevents a statement from gaining authority each time another document repeats it.

For an original example, a sponsor presentation says a roof has ten years of useful life left. An outside report quotes that presentation. A broker summary then cites the outside report. You now have three documents, but perhaps only one original source for the roof estimate. Ask whether anyone inspected the roof or read a property condition report that supports the estimate.

This does not mean a broker must personally inspect every roof. It means the reader should understand the basis of a material claim. A building specialist's work can be valuable precisely because its scope, date, and limits are clear.

Look for exclusions. An appraisal may address a stated value question under listed assumptions. A property report may cover visible conditions while excluding hidden defects. A legal opinion may address a narrow issue under specific facts. A research summary should not silently expand any of those assignments.

If a report states that it did not receive a key document, keep that gap visible in your own notes. Ask whether a later supplement supplied the missing item and whether the broker reviewed it. The first report's conclusion may need context that appears only in the supplement.

Also distinguish a report's payment from its quality. Knowing who paid is useful for assessing incentives. It does not by itself prove bias or independence. Read what the author did, what was excluded, and how the broker addressed any unresolved points.

## Look for a Record of Unresolved Questions

A thorough-looking packet can still hide unfinished work. Ask whether the review records open questions and the evidence used to close them. A question log does not need to expose every private discussion to be useful. It should let you understand the status of issues that matter to your decision.

An original log might contain eight questions. Five have answers backed by records. Two await a source, and one has an answer the reviewer has not yet assessed. The count is five closed and three still open. Calling all eight “addressed” would obscure the difference between receiving a response and deciding that it resolves the issue.

Use clear status words. “Requested,” “received,” “reviewed,” and “resolved for this purpose” describe different stages. Include the date and the person responsible for the next step. A file can be full of emails while the central question remains unanswered.

Consider a future property-tax expense. The sponsor supplies a number, but the broker asks whether it allows for a new tax assessment. A response that repeats last year's bill may be relevant without resolving the forward-looking question. The log should preserve the difference.

Avoid treating every gap as equal. A missing page number may be easy to fix. A missing source for a large cash-flow assumption can change the analysis. The useful question is how the gap affects the decision, not how many boxes remain blank.

If an issue is closed with a judgment, ask for the reasoning at a level the firm can share. “Acceptable” is less informative than an explanation of the assumption, supporting evidence, and possible downside. The explanation may still be uncertain. Clear uncertainty is more useful than an unexplained pass.

## Review Changes Between Approval and Subscription

An offering review has a cutoff date. A committee may review one packet and the investor may later receive an amendment. Ask how the firm decides whether a change needs another review and who communicates the effect to the representative and investor.

In an original timeline, a firm completes its review on October 1. A loan amendment arrives on October 8, a revised forecast on October 10, and the investor considers subscribing on October 17. The useful question is whether the advice reflects the later documents. The October 1 approval date alone cannot answer that.

Build a short change list. Name the earlier document, the later document, the changed term, and the analysis that may be affected. A debt-rate change can affect cash forecast. A reserve change can alter the amount available for other purposes. A new risk disclosure may require a fresh conversation even if the headline distribution stays the same.

Do not assume that every revision makes an offering worse. Some changes resolve uncertainty or improve terms. The process should make the change visible and explain it, rather than simply attach the new file to a growing folder.

If time is short, ask which material questions are still open. A deadline does not turn an unknown into a known fact. Your tax and legal advisers should address the consequences of the choices open to you; a sales schedule should not be mistaken for proof that the research is complete.

The SEC's private-placement bulletin, updated in September 2026, discusses limited public information, illiquidity, and the need to understand risks. It also cautions that Form D is not SEC approval. Those limits remain relevant even when a broker has reviewed an offering. [SEC private-placement bulletin](https://www.investor.gov/introduction-investing/general-resources/news-alerts/alerts-bulletins/investor-bulletins/private-placements-under-regulation-d-updated-investor-bulletin).

## Separate Offering Approval From the Investor Decision

An offering can pass a firm's product review and still be a poor fit for a specific investor. The product question asks what the offering is and how its plan works. The investor question asks what role that investment would play in the person's finances and needs.

For an original example, two investors consider the same illiquid holding. Each has $500,000 available. One needs $100,000 for a known expense next year; the other has separate funds for that expense. The offering documents do not change between those conversations, but the cash-needs discussion should.

A broker's explanation should connect the recommendation to the information actually gathered from you. If the explanation is identical for every client, ask where your circumstances enter the decision. This article does not decide what amount any reader should invest.

Keep product approval, subscription acceptance, and advice for you separate in your notes. A sponsor's acceptance of a subscription is not an independent assessment of your whole financial plan. A platform listing is not a promise that you will receive an allocation. A completed form is not proof that you understood every risk.

Ask what alternatives were discussed and why they were set aside. The answer need not be a catalog of every investment in the market. It should explain the key choices within the actual relationship and the limits of the broker's access or service.

Your final file should make clear what was decided, by whom, and on which evidence. If a personal planning question remains outside the broker's work, name the professional who will address it. That is more useful than allowing a broad “approved” label to cover several different decisions.

## Compare Research Access Without Rewarding Page Counts

More pages do not necessarily mean more usable research. A concise report with clear sources and open questions may be easier to assess than a large folder with no index. At the same time, a short summary may omit details you need. Judge whether the material answers the question, not whether it is long or short.

In an original comparison, Broker A gives an investor a 128-page packet. Broker B supplies a 34-page analysis with a source index. Both discuss the same three assumptions. The page counts alone do not show which review is stronger. You must inspect the work on those assumptions and the sources behind it.

Do the same with response speed. A same-day reply can be a useful acknowledgment without being a completed answer. A slower reply can be thorough or simply delayed. Track what the response adds: a new source, a corrected number, an explanation, or only a repeated claim.

Avoid making rejection rates into a quality measure without a defined population. A firm that reviewed ten proposed deals and accepted two has a 20% acceptance rate for that group. Another that considered fifty initial inquiries and accepted five has a 10% rate for a different group. Those percentages do not compare the same screening stage.

The missing denominator may matter more than the percentage. Were withdrawn offerings counted? Did the firm review the full packet or only an initial summary? Were the offerings in the same period and property sector? Without those details, a selectivity claim cannot support a fair ranking.

A practical comparison can stay descriptive: which materials you received, which claims you traced, and which questions remained open. That gives you a record you can revisit without turning documentation volume into an investment recommendation.

## Use a Practical Broker Due-Diligence Interview

Begin the conversation with one offering and one issue that matters to you. Ask the broker to walk through the source, the analysis, and the conclusion. Then ask what evidence could change that conclusion. This makes the process visible in a way a general statement about experience cannot.

Bring a short working sheet. Record the exact issuer, packet version, research date, key assumption, source location, reviewer role, and remaining question. Leave blanks where information is missing. The purpose is to keep the conversation accurate, not to create a perfect-looking form.

Ask what is outside the review. This can reveal whether you need help from a property specialist, tax adviser, attorney, or another professional. A clear limit can be a useful answer. It tells you which question still needs attention.

After the meeting, write a brief factual recap for your own records. Separate what the broker stated from what you inferred. If you receive a later correction, preserve both versions and note what changed. Do not silently replace the old number and lose the reason for the change.

For a structured starting point, the [Offering Screen Transparency Matrix](/writing/best-dst-brokers-offering-screen-transparency-matrix) lets you record a broker's stated criteria, scope, sources, and questions. It organizes entered evidence without rating the broker or deciding whether a legal duty was met.

A useful result from the interview may be a decision to ask for one more document. It may be a clearer understanding of an assumption you are willing to accept. It may also be a recognition that the evidence on hand does not answer a material question. Each is more informative than treating a process slogan as the end of the review.

## Frequently Asked Questions

### Does due diligence mean a DST investment is safe?

No. Research can improve understanding without eliminating property, financing, liquidity, or other investment risks. A completed review is not a guarantee of distributions, principal, or a future exit. Read the actual findings and their limits.

### Is a broker's approval the same as a regulatory approval?

No. A firm's internal decision and a regulator's role are different. A filing, registration, or internal product review should not be described as government endorsement of an investment's quality. Ask what an “approved” label means in the specific document.

### Should I expect every internal research document?

Not necessarily. Some material may be confidential or restricted. Ask what can be shared and whether the firm can explain the work on the material questions. A limit on public access is not proof that no review occurred.

### Can I rely on a third-party report without reading its scope?

You risk misunderstanding what it covers. Check the offering, date, source access, assumptions, and exclusions. Then ask how the broker used it and what later information changed the analysis. A report title alone does not show its reach.

### Does a high rejection rate identify the best DST brokers?

Not by itself. The rate needs a defined period, population, and screening stage. Even a well-defined rate describes selectivity, not the quality or future performance of accepted offerings. It should not replace a review of the actual evidence.

### What if two documents show different numbers?

Keep both references and ask for a reconciliation. The figures may use different dates or definitions, or one may be wrong. Do not average them or choose the more favorable number merely to complete a comparison.

### Were the named firms' internal processes independently audited here?

No. This article examines the cited public pages as accessed in October 2026 and uses original examples to explain a review method. It does not test private files, interview committee members, or rank the named firms' research quality.

## About Sequoia Research

Sequoia Research publishes educational research and tools about DST investments, sponsors, brokers, and the evidence behind investment claims. This article distinguishes public process descriptions from completed offering research and uses original examples to help readers ask clearer questions. It is not personal investment, legal, or tax advice and does not certify a firm's compliance or investment quality.

## Sources

- [FINRA Regulatory Notice 23-08](https://www.finra.org/rules-guidance/notices/23-08), May 9, 2023; accessed October 17, 2026. Reasonable-investigation and outside-research guidance.
- [FINRA 2026 oversight report, private placements](https://www.finra.org/rules-guidance/guidance/reports/2026-finra-annual-regulatory-oversight-report/private-placements), part of the report published December 9, 2025; accessed October 17, 2026. Industry findings and practices, not findings about the sampled firms.
- [Realized broker-dealer partner page](https://www.realized1031.com/partners/broker-dealers), undated current public page; accessed October 17, 2026. Firm-stated review roles and entity disclosure.
- [Realized advisor platform](https://www.realized1031.com/advisor), undated current public page; accessed October 17, 2026. Firm-stated report, review, and risk-tool features.
- [1031 Crowdfunding platform page](https://www.1031crowdfunding.com/investment-platform/), undated current public page; accessed October 17, 2026. Advertised document access and evaluation features; private portal not inspected.
- [1031 Crowdfunding home page and disclosure](https://www.1031crowdfunding.com/), accessed October 17, 2026. Platform and Capulent role distinction.
- [How Concorde works](https://www.concordeis.com/how-concorde-works/), undated current public page; accessed October 17, 2026. Stated professional-support model and entity disclosure.
- [SEC private-placement bulletin](https://www.investor.gov/introduction-investing/general-resources/news-alerts/alerts-bulletins/investor-bulletins/private-placements-under-regulation-d-updated-investor-bulletin), updated September 21, 2026; accessed October 17, 2026. Disclosure, illiquidity, and Form D limits. All numerical case examples in this article are original and hypothetical.


## Related Reading and Tools

- [DST Brokers: How to Choose One for Your Investment Needs](https://sequoia-research.com/writing/dst-brokers-how-to-choose-one-for-your-investment-needs)
- [Best DST 1031 Exchange Companies (2026): What a Meaningful Comparison Should Include](https://sequoia-research.com/writing/best-dst-1031-exchange-companies-2026-what-a-meaningful-comparison-should-include)
- [1031 Exchange DST Brokers: What They Do During the Exchange Process](https://sequoia-research.com/writing/1031-exchange-dst-brokers-what-they-do-during-the-exchange-process)